A vaccine for respiratory syncytial virus (RSV) is now available for older Canadians, but experts worry that cost of the vaccine could be a barrier to seniors and could lead to preventable hospitalizations — and potentially, death.
Health
Cost of RSV vaccine a barrier to older Canadians amid respiratory season, experts warn
More Videos
-
What Canadians need to know about the Bird Flu crisis
-
Health Matters: Nestle launches protein shots in U.S.
-
Doctors cite concern over polio vaccine politics in U.S.
-
Simple breathing techniques to calm your mind & body
-
Health Matters: Health Canada recalls certain Stanley mugs, Yoto Mini’s
-
A doctor’s insight on the ‘Real Housewife’ fighting facial parasites
You are viewing an Accelerated Mobile Webpage.
View Original Article